Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Galantamine”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01372306
What this trial is testing

Galantamine Bioequivalence Study of Dr. Reddy's Under Fed Condition

Who this might be right for
Fed
Dr. Reddy's Laboratories Limited 24
Not applicableStudy completedNCT02420327
What this trial is testing

Low-Dose Galantamine to Potentiate the Attention-Enhancing Effects of Low-Dose Nicotine

Who this might be right for
Basic Science Study of the Mechanisms of Attentional Enhancement by Compounds Acting on the Nicotinic Receptor
University of Maryland, Baltimore 43
Not applicableStudy completedNCT00291421
What this trial is testing

A Survey Study of the Treatment and Outcome Management in Patients Diagnosed With Alzheimer's Disease

Who this might be right for
Alzheimer DiseaseDementiaNervous System Diseases+2 more
Janssen Pharmaceutica N.V., Belgium 2,360
Not applicableStudy completedNCT00181636
What this trial is testing

Galantamine-CR and Cognitive Dysfunction in Bipolar Disorder

Who this might be right for
Bipolar Disorder
Massachusetts General Hospital 25
Testing effectiveness (Phase 2)Study completedNCT01669538
What this trial is testing

Effect of Galantamine on Short-term Abstinence

Who this might be right for
Tobacco Use Disorder
University of Pennsylvania 98
Large-scale testing (Phase 3)Study completedNCT00240695
What this trial is testing

A Follow-up Study to Assess Safety and Tolerability of Galantamine Treatment in Individuals With Mild Cognitive Impairment

Who this might be right for
Cognition DisorderNervous System DiseasesMental Disorders+1 more
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 724
Early research (Phase 1)Study completedNCT01190748
What this trial is testing

Bioequivalence Study of Galantamine 4 mg Tablet and Reminyl Following a 4 mg Dose in Healthy Subjects Under Fasting Conditions

Who this might be right for
Healthy
Actavis Inc. 24
Post-approval studies (Phase 4)Study completedNCT01478633
What this trial is testing

Evaluation of Efficacy and Safety of Galantamine in Patients With Dementia of Alzheimer's Type Who Failed to Benefit From Donepezil

Who this might be right for
Alzheimer's Disease
Janssen Pharmaceutical K.K. 102
Large-scale testing (Phase 3)Study completedNCT00304629
What this trial is testing

Long-term Safety and Efficacy of Galantamine in Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 241
Post-approval studies (Phase 4)Study completedNCT00234637
What this trial is testing

Rivastigmine Monotherapy and Combination Therapy With Memantine in Patients With Moderately Severe Alzheimer's Disease Who Failed to Benefit From Previous Cholinesterase Inhibitor Treatment

Who this might be right for
Alzheimer's Disease
Novartis 204
Post-approval studies (Phase 4)Study completedNCT00320736
What this trial is testing

Galantamine for Cognition in People With Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective Disorder
North Suffolk Mental Health Association 20
Large-scale testing (Phase 3)Study completedNCT00253214
What this trial is testing

Placebo-Controlled Evaluation of Galantamine in the Treatment of Alzheimer's Disease: Safety and Efficacy of a Controlled-Release Formulation

Who this might be right for
Alzheimer DiseaseDementia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 973
Early research (Phase 1)Study completedNCT01372280
What this trial is testing

Galantamine Bioequivalence Study of Dr. Reddy's Under Fasting Condition

Who this might be right for
Fasting
Dr. Reddy's Laboratories Limited 28
Not applicableStudy completedNCT01129479
What this trial is testing

Galantamine Treatment for Nonfluent Aphasia in Stroke Patients

Who this might be right for
AphasiaStroke
University of North Carolina, Chapel Hill 8
Testing effectiveness (Phase 2)Study completedNCT01548638
What this trial is testing

Effect of Galantamine on Smoking Abstinence

Who this might be right for
Nicotine Addiction
University of Pennsylvania 13
Testing effectiveness (Phase 2)Study completedNCT03384784
What this trial is testing

Effect of Galantamine on Inflammation and Cognition

Who this might be right for
HIV Associated Cognitive Motor Complex
University of Pennsylvania 63
Post-approval studies (Phase 4)Study completedNCT02283242
What this trial is testing

Galantamine Effects in Patients With Metabolic Syndrome

Who this might be right for
Abdominal Obesity Metabolic Syndrome
University of Sao Paulo 60
Large-scale testing (Phase 3)Study completedNCT00236574
What this trial is testing

Evaluate the Efficacy and Safety of Galantamine in Patients With Mild Cognitive Impairment

Who this might be right for
DementiaAlzheimer Disease
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 974
Post-approval studies (Phase 4)Looking for participantsNCT07633470
What this trial is testing

Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)

Who this might be right for
Alzheimer Disease
Alpha Cognition, Inc 150
Post-approval studies (Phase 4)UnknownNCT00523666
What this trial is testing

Diffusion Tensor Weighted MRI in Alzheimer's Disease Modifying Treatment Effects of Galantamine (Reminyl®)

Who this might be right for
Alzheimer's Disease
Ludwig-Maximilians - University of Munich 20
Next Page